Philadelphia cell therapy startup raises $75M, names former Biogen exec as CEO

Philadelphia gene therapy startup Limelight Bio, whose founders include researchers from the University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, has raised $75 million in venture capital financing. The investment in Limelight was made by Apple Tree Partners, a life sciences innovation fund based in New York City that also provided seed funding to launch Limelight in late 2016. Limelight is developing proprietary technologies designed to overcome limitations…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news